Teva to buy Allergan generics for $40.5 billion
July 27, 2015 at 07:57 AM EDT
Teva Pharmaceutical agrees to buy Allergan PLC’s generics business for in a deal valued at $40.5 billion, making it one of the world’s biggest drugmakers, and allowing it to drop its bid for Mylan NV.
